Von Hippel-Lindau Tumor Suppressor Protein [nádorový supresorový protein VHL]
- Terms
-
VHL protein
von Hippelova-Lindauova nemoc - nádorový supresorový protein
von Hippelův-Lindauův syndrom - nádorový supresorový protein
-
VHL Tumor Suppressor Protein
A ubiquitin-protein ligase that mediates OXYGEN-dependent polyubiquitination of HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT. It is inactivated in VON HIPPEL-LINDAU SYNDROME.
- DUI
- D051794 MeSH Browser
- CUI
- M0481855
- History note
- 2006 (1995)
- Public note
- 2006; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN was indexed under TUMOR SUPPRESSOR PROTEINS 2002-2005, under UBIQUITIN-PROTEIN LIGASES 2004-2005, under LIGASES 2002-3003, under PROTEINS 1995-2001, & under NUCLEAR PROTEINS 1995
Combination
- deficiency
- von Hippel-Lindau Disease
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AN
- analysis 1
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DE
- drug effects
- EC
- economics
- GE
- genetics 25
- HI
- history
- IM
- immunology
- IP
- isolation & purification 1
- ME
- metabolism 7
- PK
- pharmacokinetics
- PD
- pharmacology 1
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine
VHL protein, human Chemical MeSH Browser
VHL protein, mouse Chemical MeSH Browser
VHLL protein, human Chemical MeSH Browser